A founder mutation in the MPL gene causes congenital amegakaryocytic thrombocytopenia (CAMT) in the Ashkenazi Jewish population.

[1]  Minjie Luo,et al.  Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases , 2010, Human mutation.

[2]  P. Rosenberg,et al.  Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry , 2008, Haematologica.

[3]  M. Ballmaier,et al.  Advances in the understanding of congenital amegakaryocytic thrombocytopenia , 2009, British journal of haematology.

[4]  N. Fox,et al.  Compound heterozygous c-Mpl mutations in a child with congenital amegakaryocytic thrombocytopenia: functional characterization and a review of the literature. , 2009, Experimental hematology.

[5]  A. Geddis.  Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. , 2009, Hematology/oncology clinics of North America.

[6]  B. Kerlin,et al.  Congenital amegakaryocytic thrombocytopenia: The diagnostic importance of combining pathology with molecular genetics , 2008, Pediatric blood & cancer.

[7]  P. Noris,et al.  Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations , 2007, Haematologica.

[8]  M. Ballmaier,et al.  MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease , 2006, Human mutation.

[9]  M. Ballmaier,et al.  Congenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of 20 patients , 2005, British journal of haematology.

[10]  M. Slatkin.  A population-genetic test of founder effects and implications for Ashkenazi Jewish diseases. , 2004, American journal of human genetics.

[11]  M. Ayas,et al.  Allogeneic stem cell transplantation for patients with congenital amegakaryocytic thrombocytopenia (CAT) , 2004, Bone Marrow Transplantation.

[12]  I. Roberts,et al.  Neonatal thrombocytopenia: causes and management , 2003, Archives of disease in childhood. Fetal and neonatal edition.

[13]  M. Ballmaier,et al.  Thrombopoietin Is Essential for the Maintenance of Normal Hematopoiesis in Humans , 2003, Annals of the New York Academy of Sciences.

[14]  V. Sutton,et al.  Tay-Sachs disease screening and counseling families at risk for metabolic disease. , 2002, Obstetrics and gynecology clinics of North America.

[15]  S. Kojima,et al.  Successful engraftment of unrelated donor stem cells in two children with congenital amegakaryocytic thrombocytopenia. , 2002, Journal of pediatric hematology/oncology.

[16]  M. Ballmaier,et al.  c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. , 2001, Blood.

[17]  H. Katzenstein,et al.  The Dor Yeshorim story: community-based carrier screening for Tay-Sachs disease. , 2001, Advances in genetics.

[18]  Michael M. Kaback,et al.  Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model , 2000, European Journal of Pediatrics.

[19]  L. Rimsza,et al.  Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit. , 2000, Clinics in perinatology.

[20]  L. Vitale,et al.  Compound heterozygosity for two different amino-acid substitution mutations in the thrombopoietin receptor (c-mpl gene) in congenital amegakaryocytic thrombocytopenia (CAMT) , 2000, Human Genetics.

[21]  C. Folman,et al.  Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia , 2000, British journal of haematology.

[22]  B. Kremens,et al.  Haematopoietic stem cell transplantation for amegakaryocytic thrombocytopenia , 2000, British journal of haematology.

[23]  M. Eguchi,et al.  Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Maślanka,et al.  Neonatal Thrombocytopenia: Incidence, Serological and Clinical Observations , 1997, American journal of perinatology.

[25]  V. Blanchette,et al.  Platelet disorders in newborn infants: diagnosis and management. , 1997, Seminars in perinatology.

[26]  I. Roberts,et al.  Circulating Megakaryocytes and Their Progenitors in Early Thrombocytopenia in Preterm Neonates , 1996, Pediatric Research.

[27]  A. Homans.  Thrombocytopenia in the neonate. , 1996, Pediatric clinics of North America.

[28]  P. Ljungman,et al.  Bone marrow transplantation in two children with congenital amegakaryocytic thrombocytopenia. , 1995, Bone marrow transplantation.

[29]  A. Motulsky.  Jewish diseases and origins , 1995, Nature Genetics.

[30]  Z. Estrov,et al.  Congenital Amegakaryocytic Thrombocytopenia: An Intrinsic Hematopoietic Stem Cell Defect , 1990, The American journal of pediatric hematology/oncology.

[31]  J. Kelton,et al.  Frequency and mechanism of neonatal thrombocytopenia. , 1986, The Journal of pediatrics.

[32]  D. Boggs.  Amegakaryocytic thrombocytopenia , 1985, American journal of hematology.

[33]  L Neumann,et al.  Thrombocytopenia in the high-risk infant. , 1980, The Journal of pediatrics.

[34]  F. Oski,et al.  Hematology of Infancy and Childhood , 1974 .